Exogenous ochronosis: Screening by dermoscopy and histopathological confirmation

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


A 51-year-old female presented with a 10-year history of brownish skin marks on her cheeks. Dermatological examination showed malar brownish macular lesions with diffused reddish areas and superimposing brownish papules. Further dermoscopic examination showed short circinate brownish-red structures and cutaneous pseudo-rete accentuation. Histopathological examination confirmed Stage II exogenous ochronosis (EO). Hydroquinone is the most commonly used topical agent for hyperpigmentation skin disorders. One side effect of its long-term use is EO. Clinically, EO is difficult to diagnose, and clinicians should be more aware of this condition. Dermoscopy is an in vivo diagnostic tool that is used to enhance the visualization of cutaneous lesions. The use of this device can potentially assist in identifying the progress of melasma disorder into EO.

Original languageEnglish
Pages (from-to)S163-S165
JournalJournal of Natural Science, Biology and Medicine
Issue number3
Publication statusPublished - Nov 2019


  • Dermoscopy
  • exogenous ochronosis
  • pathology


Dive into the research topics of 'Exogenous ochronosis: Screening by dermoscopy and histopathological confirmation'. Together they form a unique fingerprint.

Cite this